Clinical Trial Update: National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study

View source ↗

Summary

A completed clinical trial evaluating dendritic cell-specific transmembrane protein (DC-Stamp) as a biomarker in psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Snippet

Sponsor: University of Rochester | Conditions: Psoriatic Arthritis | Status: COMPLETED